These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1985045)

  • 1. Selective intestinal decontamination prevents spontaneous bacterial peritonitis.
    Soriano G; Guarner C; Teixidó M; Such J; Barrios J; Enríquez J; Vilardell F
    Gastroenterology; 1991 Feb; 100(2):477-81. PubMed ID: 1985045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage.
    Soriano G; Guarner C; Tomás A; Villanueva C; Torras X; González D; Sainz S; Anguera A; Cussó X; Balanzó J
    Gastroenterology; 1992 Oct; 103(4):1267-72. PubMed ID: 1397884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of hospital bacterial infections in cirrhotic patients undergoing selective intestinal decontamination].
    Tomás A; Soriano G; Guarner C; Teixidó M; Méndez C; Tena F; Fábrega E; Villanueva C; Such J; Balanzó J
    Rev Esp Enferm Dig; 1991 Apr; 79(4):259-64. PubMed ID: 2054213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes.
    Llovet JM; Rodríguez-Iglesias P; Moitinho E; Planas R; Bataller R; Navasa M; Menacho M; Pardo A; Castells A; Cabré E; Arroyo V; Gassull MA; Rodés J
    J Hepatol; 1997 Jan; 26(1):88-95. PubMed ID: 9148028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial.
    Ginés P; Rimola A; Planas R; Vargas V; Marco F; Almela M; Forné M; Miranda ML; Llach J; Salmerón JM
    Hepatology; 1990 Oct; 12(4 Pt 1):716-24. PubMed ID: 2210673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Variation of C3 in ascitic fluid from cirrhotic patients subjected to intestinal sterilization or selective intestinal decontamination].
    Soriano G; Teixidó M; Guarner C; Such J; Espinós JC; Sainz S; Enríquez J; Rodríguez JL; Vilardell F
    Rev Esp Enferm Apar Dig; 1989 Feb; 75(2):123-6. PubMed ID: 2710995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.
    Corradi F; Brusasco C; Fernández J; Vila J; Ramirez MJ; Seva-Pereira T; Fernández-Varo G; Mosbah IB; Acevedo J; Silva A; Rocco PR; Pelosi P; Gines P; Navasa M
    Dig Liver Dis; 2012 Mar; 44(3):239-44. PubMed ID: 22119621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Sandhu BS; Gupta R; Sharma J; Singh J; Murthy NS; Sarin SK
    J Gastroenterol Hepatol; 2005 Apr; 20(4):599-605. PubMed ID: 15836710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.
    Alvarez RF; Mattos AA; Corrêa EB; Cotrim HP; Nascimento TV
    Arq Gastroenterol; 2005; 42(4):256-62. PubMed ID: 16444382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
    Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C; Kumar A; Sarin SK
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
    Assem M; Elsabaawy M; Abdelrashed M; Elemam S; Khodeer S; Hamed W; Abdelaziz A; El-Azab G
    Hepatol Int; 2016 Mar; 10(2):377-85. PubMed ID: 26660707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial?
    Cholongitas E; Papatheodoridis GV; Manesis EK; Burroughs AK; Archimandritis AJ
    J Gastroenterol Hepatol; 2006 Mar; 21(3):581-7. PubMed ID: 16638103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis.
    Runyon BA; Borzio M; Young S; Squier SU; Guarner C; Runyon MA
    Hepatology; 1995 Jun; 21(6):1719-24. PubMed ID: 7768517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis.
    Such J; Guarner C; Soriano G; Teixidó M; Barrios J; Tena F; Méndez C; Enríquez J; Rodríguez JL; Vilardell F
    Hepatology; 1990 Nov; 12(5):1175-8. PubMed ID: 2227816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
    Yim HJ; Suh SJ; Jung YK; Yim SY; Seo YS; Lee YR; Park SY; Jang JY; Kim YS; Kim HS; Kim BI; Um SH
    Am J Gastroenterol; 2018 Aug; 113(8):1167-1176. PubMed ID: 29946179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on ascitic fluid protein level in cirrhotic patients with spontaneous bacterial peritonitis.
    Mustafa MG; Al Mamun MA; Alam AK
    Bangladesh Med Res Counc Bull; 2009 Aug; 35(2):41-3. PubMed ID: 20120777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis.
    Francés R; González-Navajas JM; Zapater P; Muñoz C; Caño R; Pascual S; Márquez D; Santana F; Pérez-Mateo M; Such J
    J Clin Immunol; 2007 Jul; 27(4):438-44. PubMed ID: 17404822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.